<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03983304</url>
  </required_header>
  <id_info>
    <org_study_id>ZA19-002</org_study_id>
    <nct_id>NCT03983304</nct_id>
  </id_info>
  <brief_title>EMS for Abdominal and Gluteal Muscle Toning</brief_title>
  <acronym>CTP</acronym>
  <official_title>Electromagnetic Muscle Stimulation for Abdominal and Gluteal Muscle Toning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zeltiq Aesthetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zeltiq Aesthetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the use of Electromagnetic Muscle Stimulation for body contouring.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 10, 2019</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy Endpoint: Subject Satisfaction Questionnaire</measure>
    <time_frame>4-wk follow up visit</time_frame>
    <description>Measurement of subject feeling about body shape, assessed using the Body Satisfaction Scale at the 4-Week follow-up visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Global Aesthetic Improvement Scale (GAIS)</measure>
    <time_frame>4-wk follow up visit</time_frame>
    <description>Subject-graded improvement in the treated area using the Subject Global Aesthetic Scale (SGAIS) at the 4-Week follow-up visit.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>Muscle Toning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatments are designed to evaluate muscle toning, firming and strengthening in the abdomen and buttocks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The ZELTIQ System</intervention_name>
    <description>The EMS device will be used to perform the treatments.</description>
    <arm_group_label>Muscle Toning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Male or female ≥ 22 years and ≤65 years of age.

          -  Subject has not had weight change exceeding 5% of body weight in the preceding month.

          -  Subject agrees to maintain body weight within 5% during the study by not making any
             changes in diet or exercise routine.

          -  Subject has a BMI ≤ 30 as determined at screening.

          -  Subject agrees to have photographs taken of the treatment area(s) during the scheduled
             time periods.

          -  Subject agrees to refrain from any new abdominal and/or gluteal muscle training
             exercises of the treatment area during the course of the study.

          -  Subject agrees to avoid sun tanning during the course of the study.

          -  Subject has read and signed the study written informed consent form.

        Exclusion Criteria

          -  Subject has had a recent surgical procedure(s) in the area of intended treatment and
             muscle contractions may disrupt the healing process.

          -  Subject has had an invasive fat reduction procedure (e.g., liposuction, mesotherapy)
             in the area of intended treatment.

          -  Subject needs to administer or has a known history of subcutaneous injections into the
             area of intended treatment (e.g., heparin, insulin) within the past month.

          -  Subject has not had an intrauterine contraceptive device inserted or removed within
             the past month.

          -  Subject has a bleeding disorder

          -  Subject is taking or has taken diet pills or supplements within the past month.

          -  Subject has a metal implant or active implanted device such as a cardiac pacemaker,
             cochlear implant, intrathecal pump, hearing aids, defibrillator, or drug delivery
             system.

          -  Subject agrees not to change muscle exercise routine in the treatment area (abdominal
             and/or gluteal) while participating in the study

          -  Subject has pulmonary insufficiency.

          -  Subject has a cardiac disorder.

          -  Subject has a malignant tumor.

          -  Subject has been diagnosed with a seizure disorder such as epilepsy.

          -  Subject currently has a fever.

          -  Subject is diagnosed with Grave's disease.

          -  Subject is pregnant or intending to become pregnant during the study period (in the
             next 9 months).

          -  Subject is lactating or has been lactating in the past 6 months.

          -  Subject is unable or unwilling to comply with the study requirements.

          -  Subject is currently enrolled in a clinical study of any other investigational drug or
             device.

          -  Any other condition or laboratory value that would, in the professional opinion of the
             Investigator, potentially affect the subject's response or the integrity of the data
             or would pose an unacceptable risk to the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kerrie Jiang, NP</last_name>
    <role>Study Director</role>
    <affiliation>Zeltiq Aesthetics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Marina Plastic Surgery</name>
      <address>
        <city>Marina Del Rey</city>
        <state>California</state>
        <zip>90292</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Innovation Research Center</name>
      <address>
        <city>Pleasanton</city>
        <state>California</state>
        <zip>94588</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cosmetic Laser Dermatology</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bowes Dermatology by Riverchase</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Laser &amp; Skin Care</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SkinCare Physicians of Chestnut Hill</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EpiCentre Park Lane</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 10, 2019</study_first_submitted>
  <study_first_submitted_qc>June 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

